Figure 2From: Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit? sPGE2 levels before and 4 weeks after BoNT-A treatment (p < 0.005). Back to article page